Riik: Austraalia
keel: inglise
Allikas: Department of Health (Therapeutic Goods Administration)
telmisartan, Quantity: 80 mg
Arrotex Pharmaceuticals Pty Ltd
Tablet
Excipient Ingredients: povidone; sodium hydroxide; magnesium stearate; meglumine; mannitol
Oral
56 tablets, 98 tablets, 30 tablets, 14 tablets, 7 tablets (sample), 28 tablets
(S4) Prescription Only Medicine
Telmisartan is indicated for: Treatment of hypertension. Prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see CLINICAL TRIALS).
Visual Identification: White to off-white, oblong, uncoated tablets about 16.10mm length and 7.80mm width with 'C' debossed one side and '05' debossed on the other.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius
Registered
2019-03-14